Literature DB >> 16996192

Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C.

Jeong-Hun Kang1, Yuhua Jiang, Riki Toita, Jun Oishi, Kenji Kawamura, Aishan Han, Takeshi Mori, Takuro Niidome, Masami Ishida, Kenji Tatematsu, Katsuyuki Tanizawa, Yoshiki Katayama.   

Abstract

Rho-associated kinase (Rho-kinase/ROCK/ROK) is a serine/threonine kinase and plays an important role in various cellular functions. The cAMP-dependent protein kinase (protein kinase A/PKA) and protein kinase C (PKC) are also serine/threonine kinases, and directly and/or indirectly take part in the signal transduction pathways of Rho-kinase. They have similar phosphorylation site motifs, RXXS/T and RXS/T. The purpose of this study was to identify whether sites phosphorylated by Rho-kinase could be targets for PKA and PKC and to find peptide substrates that are specific to Rho-kinase, i.e., with no phosphorylation by PKA and PKC. A total of 18 substrates for Rho-kinase were tested for phosphorylation by PKA and PKC. Twelve of these sites were easily phosphorylated. These results mean that Rho-kinase substrates can be good substrates for PKA and/or PKC. On the other hand, six Rho-kinase substrates showing no or very low phosphorylation efficiency (<20%) for PKA and PKC were identified. Kinetic parameters (K(m) and k(cat)) showed that two of these peptides could be useful as substrates specific to Rho-kinase phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996192     DOI: 10.1016/j.biochi.2006.08.003

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  23 in total

1.  Rho kinase activity governs arteriolar myogenic depolarization.

Authors:  Yao Li; Joseph E Brayden
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-07       Impact factor: 6.200

2.  Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux.

Authors:  Stamatia Rontogianni; Sedef Iskit; Sander van Doorn; Daniel S Peeper; Maarten Altelaar
Journal:  Mol Cell Proteomics       Date:  2019-11-26       Impact factor: 5.911

3.  Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Authors:  Guokai Chen; Zhonggang Hou; Daniel R Gulbranson; James A Thomson
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

4.  Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance.

Authors:  Shufang Zheng; Lifang Shi; Yi Zhang; Tao He
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets.

Authors:  Zhenhan Deng; Yiming Jia; Haifeng Liu; Miao He; Yuntao Yang; Wenfeng Xiao; Yusheng Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

6.  Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA alters amyloid-beta production.

Authors:  Jeremy H Herskowitz; Nicholas T Seyfried; Marla Gearing; Richard A Kahn; Junmin Peng; Allan I Levey; James J Lah
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

7.  Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration.

Authors:  Alice V Schofield; Rohan Steel; Ora Bernard
Journal:  J Biol Chem       Date:  2012-10-23       Impact factor: 5.157

Review 8.  Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.

Authors:  Linda Julian; Michael F Olson
Journal:  Small GTPases       Date:  2014-07-10

Review 9.  ROCK as a therapeutic target for ischemic stroke.

Authors:  Nikola Sladojevic; Brian Yu; James K Liao
Journal:  Expert Rev Neurother       Date:  2017-10-30       Impact factor: 4.618

10.  Effect of the addition of diammonium citrate to alpha-cyano-4-hydroxycinnamic acid (CHCA) matrix for the detection of phosphorylated peptide in phosphorylation reactions using cell and tissue lysates.

Authors:  Jeong-Hun Kang; Riki Toita; Jun Oishi; Takuro Niidome; Yoshiki Katayama
Journal:  J Am Soc Mass Spectrom       Date:  2007-08-15       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.